This topic contains a solution. Click here to go to the answer

Author Question: While a patient is receiving an aminoglycoside medication by intramuscular injection, the provider ... (Read 110 times)

Bob-Dole

  • Hero Member
  • *****
  • Posts: 547
While a patient is receiving an aminoglycoside medication by intramuscular injection, the provider should instruct the patient to expect:
 
  a. discomfort to the injection site, which can be treated with warm moist heat.
  b. development of localized infection, which can be treated with an occlusive dressing.
  c. discomfort to the injection site, which can best be relieved with narcotic analgesics.
  d. development of localized bleeding, which may require the application of an occlusive dressing.

Question 2

A patient who was recently hospitalized and treated with gentamicin tells the primary care NP, My kidney function test was abnormal and they stopped the medication. The patient is worried about long-term effects. The NP should:
 
  a. monitor renal function for several months.
  b. reassure the patient that complete recovery should occur.
  c. refer the patient to a nephrologist for follow-up evaluation.
  d. monitor serum electrolytes and serum creatinine and BUN.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Hikerman221

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

A
The administration of aminoglycosides by intramuscular injection may cause discomfort to the injection site, which can be treated with warm moist heat and mild analgesics.

Answer to Question 2

B
Recovery of renal function occurs if the drug is stopped at the first sign of renal impairment. It is necessary to monitor blood values during therapy to ensure effectiveness and prevent toxicity.



Bob-Dole

  • Hero Member
  • *****
  • Posts: 547
Both answers were spot on, thank you once again




 

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

For a complete list of videos, visit our video library